🧬 Virax Biolabs (Nasdaq: VRAX): A Clinical-Stage Diagnostics Company Targeting a $25B+ Unmet Need in Post-Acute Infection Syndromes
Up to 21 million Americans are living with Long COVID, ME/CFS, and post-treatment Lyme disease — yet there is currently no widely adopted objective diagnostic test for these conditions.
Virax Biolabs is developing ViraxImmune™, a potential first-in-category immune profiling test designed to objectively assess immune dysfunction in chronic post-infection conditions — with U.S. commercialization planned for 2027.
ViraxImmune™ is informed by UK NHS-linked clinical studies and independent U.S. validation work conducted at Emory University.
🎥 Watch our 30-second investor brief on Virax Biolabs:
https://t.co/Zz3t3rJjr8
$VRAX $PACB $VYGR $PFE $MRK
#VRAX #ViraxBiolabs #LongCOVID #MECFS #Diagnostics #Biotech #Nasdaq #Investing
ASP Isotopes (Nasdaq: ASPI) | Investor Webinar | June 17 at 11:00 AM ET — Mark Your Calendar
The critical materials supply chain is being redrawn — and ASP Isotopes is positioning itself at the center of it. From isotope enrichment facilities now in commercial production in South Africa to a transformational acquisition that expands ASPI into helium and natural gas, the company's June 17th investor webinar is the opportunity to understand why this story is accelerating.
Why investors are watching:
- Signed definitive agreements with TerraPower (founded by Bill Gates) to supply up to 150 MT of HALEU over 10 years beginning 2028
- Joint venture with Fermi America (co-founded by former U.S. Energy Secretary Rick Perry) to build a HALEU enrichment and stable isotope facility at the 11GW HyperGrid campus in Texas
- Global HALEU demand valued at $37B+ through 2037, with structural Western shortages in Silicon-28, Ytterbium-176, Nickel-64, and Lithium-6/7 historically supplied by Russia and China
Register now to secure your spot for the June 17 webinar and hear directly from ASPI's leadership on the company's commercial trajectory and growth roadmap.
Register here: https://t.co/yDWuOCy9BP
$ASPI $SMR $NNE $OKLO $UUUU $CEG $VST $CCJ $UEC $LEU $GEV $BEP
Nexalin Technology (Nasdaq: NXL) Investor Webinar | June 17, 2026 | 4:15 PM ET — Mark Your Calendar
The global mental health crisis is one of the most consequential investment themes in healthcare today, and Nexalin Technology is building a differentiated platform squarely at its center. Mark your calendar for June 17 at 4:15 PM ET, when President and CEO Mark White will present live in an exclusive RedChip investor webinar.
Why investors are watching:
- Pivotal, randomized, triple-blinded clinical trial of the HALO™ Clarity headset for insomnia is underway
- NeuroCare® AI-driven virtual clinic, developed in collaboration with UC San Diego, enables at-home treatment, real-time physician monitoring, and a subscription-based recurring revenue model
- Gen-2 device approved in China, Brazil, and Oman
- Mental health market projected to reach $537 billion by 2030
Hear directly from President and CEO Mark White — register now to secure your spot at this exclusive virtual event.
Register here: https://t.co/ayUKKG8C8F
$NXL $VRTX $STIM $NMTC $LLY $AMGN $REGN $GILD $MRNA
🚨 TODAY: Foremost Clean Energy (Nasdaq: FMST | CSE: FAT) Virtual Investor Webinar — June 3, 2026 at 4:15 PM ET
Today is the day. The Foremost Clean Energy virtual investor webinar goes live at 4:15 PM ET, and management is ready to walk investors through the full story. If you're tracking uranium or critical minerals, this is a webinar worth blocking your afternoon for.
☢️ What's on the table today:
• 330,000+ acres across 10 uranium properties in the Athabasca Basin, one of the world's highest-grade uranium jurisdictions
• Projects positioned along the La Rocque Corridor adjacent to IsoEnergy's Hurricane deposit (48.6M lbs at 34.5% U₃O₈) — underscoring the discovery potential of the surrounding terrain
• Denison Mines Corp. (NYSE American: DNN) holds ~15.8% of FMST and provides board-level oversight, historical drill data, and geophysical expertise — a structural advantage for a junior explorer
• 2026 drill programs designed to test mineralized zone extensions and pursue new discoveries across multiple high-priority targets simultaneously
Join live at 4:15 PM ET today. Register now if you haven't already — don't miss this one.
🔗 Register here: https://t.co/0Ymqz3XHck
#FMST #ForemostCleanEnergy #Uranium #AthabascaBasin #NasdaqStocks #UraniumStocks #NuclearEnergy #InvestorWebinar #SmallCapInvesting #CriticalMinerals
Off The Hook $OTH is executing on a growth strategy investors should be watching closely.
In our latest interview, CEO Brian John breaks down Off The Hook's growth strategy, key expansion drivers, and why the company believes it is positioned for meaningful upside.
$OTH is not pitching a traditional dealership model. The company is building a vertically integrated, tech-enabled platform in a fragmented market, with multiple levers for growth across inventory turnover, acquisitions, and higher-margin add-on services.
For investors looking for emerging small-cap stories with revenue growth, acquisition upside, and a differentiated operating model, this is an interview worth watching.
Watch our full interview: https://t.co/2tYWTsmhiP
$OTH $BC $HZO $MBUU $ONEW $MCFT $MPX $WGO
⚛️ Uranium is back in focus as energy security and nuclear demand accelerate.
In our exclusive interview, Foremost Clean Energy CEO Jason Barnard (Nasdaq: FMST) explains how the company is positioning in the Athabasca Basin with a 10-property portfolio (330,000+ acres) and a strategic relationship with Denison Mines Corp that helps guide drill targeting.
🔗 Watch our full interview: https://t.co/ksoHtClHdT
$FMST $DNN $CCJ $UEC $NXE $UUUU $RIO $SQM $ALB
60 Degrees Pharma $SXTP CEO Geoff Dow on ARAKODA Commercial Growth and Key Milestones
In our discussion, Geoff walks through how $SXTP is scaling ARAKODA commercialization through new demand channels, including GoodRx and a travel-focused telehealth partner, while advancing tafenoquine into babesiosis, a tick-borne disease with no FDA approved treatments today.
Watch our full interview: https://t.co/7kD24A49OL
$SXTP $GDRX $VRTX $LLY $NVO $PFE $VALN $REGN
Velo3D (Nasdaq: $VELO): Advanced Metal 3D Printing Hits an Inflection Point in Aerospace and Defense
Additive manufacturing has been a promising technology for years — but Velo3D is now delivering the numbers that suggest it's becoming a true production technology.
Key Investor Takeaways:
• Rapid Production Solutions (RPS): Velo3D's evolving business model now generates recurring revenue streams tied to production contracts, providing greater forward visibility
• Defense & aerospace adoption: Qualified programs converting into full-scale production activity across commercial and defense aerospace customers
• Turnaround trajectory: The stock has returned 322% over the past 6 months as the financial narrative shifts from development-stage to production-scale
Velo3D's Sapphire family of metal 3D printers and Intelligent Fusion manufacturing process are enabling customers to build mission-critical metal parts with geometries previously impossible through conventional manufacturing.
CEO Arun Jeldi and CFO Jim Suva present at 12:00 PM ET on June 10.
Register free: https://t.co/F6isjDz8Ci
$VELO $DM $MKFG $SSYS $DDD $HWM
NioCorp: CEO Mark Smith on U.S. DoW Grant & Financing Momentum
@NioCorp $NB CEO Mark Smith just walked through a milestone-packed 2025 and why 2026 could be even bigger. NioCorp is positioning Elk Creek as a U.S.-based critical minerals source with potential government-backed financing, tier-one partnerships, and offtake visibility, all while maintaining meaningful liquidity and no long-term debt on the balance sheet.
Watch our full interview with CEO Mark Smith: https://t.co/EuTcCEzv7p
$NB $MP $ARA $ILU $PPTA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO
Alliance Entertainment $AENT: Executive Chairman Bruce Ogilvie on the Structural Margin Reset and Expanding Exclusive Content Platform
$AENT Executive Chairman Bruce Ogilvie outlines how Alliance Entertainment has evolved from a pure distributor into a platform capturing premium physical media, proprietary collectibles, and technology-enabled authentication — with $1.063B in trailing revenue and a structurally improved margin profile.
The company distributes 340,000+ SKUs to 35,000+ storefronts and 200+ online retailers globally. Exclusive distribution and licensing agreements — including Paramount Pictures and Amazon MGM Studios — now account for $365M, or 33% of total revenue.
Watch the full interview: https://t.co/DbukK4SV3l
$AENT $AMZN $MGM $FNKO $SONY $DIS $PARA $WBD $NTDOY
Gorilla Technology (Nasdaq: $GRRR): $107M Convertible Bond Offering Directly Funds the Yotta India GPU Deployment
Gorilla Technology has priced $107M of 7.50% Senior Unsecured Convertible Notes due 2031, expected to close on or about June 5, 2026. The financing is being led by Highbridge Capital Management, an existing institutional stakeholder, with net proceeds designated to fund the equity portion of data center equipment purchases for Gorilla's second Yotta Data Services project.
Why Investors Should Be Watching:
- Capital matched to execution: The financing is tied directly to infrastructure deployment rather than general corporate purposes, supporting Gorilla's Yotta India buildout
- Existing investor increases commitment: Highbridge's participation suggests a current institutional stakeholder is willing to provide additional capital as the project advances
- Defined conversion mechanics: The notes carry an initial conversion price of approximately $25.48 per share, a 17% premium over the closing price on June 2
- Efficient capital markets execution: The offering was completed through an existing F-3 shelf registration, allowing the company to access capital without launching a new registration process
For the full announcement: https://t.co/XAPHakRCxd
$GRRR $DGII $CSCO $MSFT $HON $AVGO $ORCL $HPE $FTNT $FYBR $CRWD $DDOG
OwlTing Group $OWLS: Ohio Money Transmitter License Extends Regulated Settlement Network to 42 U.S. States
The latest approval adds another key market to OwlTing's state-by-state licensing strategy as the company continues building infrastructure for cross-border payments, digital currency settlement, and the next generation of AI-enabled agentic commerce.
Why Investors Should Be Watching:
- Ohio is the 7th-largest U.S. state economy and a major hub for aerospace, defense, and advanced manufacturing industries that rely on cross-border payments
- Expanding regulatory moat: Each new license broadens OwlPay's addressable market and strengthens a regulatory foundation that can take years to assemble
- Enterprise adoption continues to grow: in 1Q26, OwlPay Harbor onboarded 20+ enterprise clients representing more than $5B in annualized payment volume
For the full announcement: https://t.co/WsMY87882X
$OWLS $COIN $PYPL $SQ $NATL $MARA $RIOT $MSTR $NVDA
🚨 BioVie (Nasdaq: $BIVI): Advancing the First New Parkinson’s Treatment in 50 Years
With over 1M Americans living with Parkinson’s, BioVie is developing bezisterim: a first-in-class oral therapy targeting inflammation and insulin resistance.
🔬 Following promising Phase 2 results, BioVie has launched its Phase 2b Parkinson’s trial and recently enrolled the first patient.
🎥 Watch our 30-sec overview: https://t.co/aau61o8Ezv
$BIVI $SXTP $INAB $DMAC $BFRG $NSRX $CLDI $NXL $CNTB $LTRN $KYNB $ANIX
⏰ One Week Away: RedChip's Future Tech Investor Conference Returns June 10
Next Wednesday, RedChip's Future Tech Investor Conference goes live with 13 company presentations from executives at the forefront of AI, automation, advanced manufacturing, and digital infrastructure — all followed by live investor Q&A.
The macro backdrop makes this one count. AI infrastructure spending is projected to surpass $800 billion in 2026, and Wall Street is actively rotating toward the companies enabling that buildout. The question for investors: which small and mid-cap names are positioned to capture real value?
This conference gives you a direct line to management at companies operating across some of the most consequential technology sectors of this decade:
📊 What's on the Schedule:
ASP Isotopes (NASDAQ: ASPI) – Critical minerals & isotope enrichment technology
Everspin Technologies (NASDAQ: MRAM) – Persistent MRAM memory for AI, industrial & defense
Velo3D (NASDAQ: VELO) – Metal 3D printing for SpaceX, Honeywell & mission-critical applications
LanzaTech (NASDAQ: LNZA) – Carbon capture & transformation technology
Eco Wave Power (Nasdaq: WAVE) – Next-generation wave energy solutions
BIO-key International (OTC: BKYI) – Biometric identity & cybersecurity
Syntec Optics (Nasdaq: OPTX) – Precision optics & photonics
Plus AINOS (NASDAQ: AIMD), Abundia Global (NYSE American: AGIG), Skyline Builders (NASDAQ: SKBL), RanMarine, SubSea, and Hi Solutions
📅 June 10, 2026 | 9:30 AM ET | Virtual & Free
Registration is open now — secure your spot before the week gets away from you.
👉 Register here: https://t.co/F6isjDz8Ci
#FutureTech #InvestorConference #AI #MRAM #3DPrinting #CarbonCapture #SmallCapStocks #Nasdaq #InvestorEvent #RedChip #TechInvesting
Comprehensive Healthcare Systems $CMHSF | $CHS combines recurring SaaS revenue, strong retention, and contract growth in a healthcare market still dominated by legacy systems.
In our investor overview, CEO Chris Cosgrove explains how CHS is modernizing benefits and pension administration through its Novus 360 platform across the Taft-Hartley union and self-funded employer markets.
For investors looking for underfollowed healthcare technology companies with sticky revenue and scalable economics, $CMHSF is a story worth a closer look.
Watch our full overview: https://t.co/AtfSJ9Yyj2
$CMHSF $CHS $VEEV $GEHC $PME $TDOC $DOCS $HIMS $CERT $DH $TEM $ALKT
SharonAI $SHAZ: GPU Cloud Infrastructure Positioned to Benefit From Rising Enterprise AI Demand
AI growth is increasingly limited by computing capacity. As AI infrastructure spending rises, providers scaling cloud GPU compute for enterprise workloads stand to benefit.
@Sharon__AI recently raised $125M to scale cloud GPU infrastructure for enterprise AI workloads, with additional credibility from its ecosystem alignment through Cisco and Nvidia, and a strong positioning in the accelerating demand for high-performance AI compute.
Watch our $SHAZ investor brief: https://t.co/OlTQPiSm67
$SHAZ $NVDA $CSCO $CRWV $NBIS $APLD $IREN $VRT $SMCI $PSTG $ANET
Uranium is back in focus as energy security and nuclear demand accelerate.
In our exclusive interview, @FMSTCleanEnergy CEO Jason Barnard $FMST explains how the company is positioning in the Athabasca Basin with a 10-property portfolio (330,000+ acres) and a strategic relationship with Denison Mines $DNN that helps guide drill targeting.
Watch our full interview: https://t.co/d9L0T5nxsf
$FMST $FAT.C $DNN $DML $CCJ $UEC $NXE $UUUU $RIO $SQM $ALB
OBOOK Holdings $OWLS: OwlTing CEO Darren Wang on Building the Regulatory and Settlement Infrastructure for Enterprise Stablecoin Payments
$OWLS founder and CEO Darren Wang outlines the regulatory-first strategy behind OwlTing's global payments infrastructure — and why four-plus years of licensing buildout across the U.S., Japan, and EU creates a structural barrier to entry in enterprise stablecoin settlement.
Why investors are watching:
- USD $3.84M revenue in 1H25; Gross Payment Volume exceeded USD $110M in 1H25
- Licensed in the U.S. (40+ state money transmitter licenses per CEO), Japan, and EU
- Circle Payments Network integration enabling USDC settlement to bank accounts and debit cards in 100+ countries
- OwlPay Cash collaboration with Visa supports stablecoin onboarding
- 4,100+ active accounts; 2,700+ hospitality SaaS providers generating recurring transaction demand
Watch the full CEO interview: https://t.co/vkDbtFo8QX
$OWLS $COIN $PYPL $SQ $NATL $MARA $RIOT $MSTR $NVDA
BioVie $BIVI is advancing a focused pipeline aimed at major unmet needs in neurodegeneration and serious liver disease.
In our exclusive interview, @BioVie_Pharma CEO Cuong Do explains what the next Parkinson’s milestone could signal, why the company is pursuing Long COVID as a meaningful new opportunity, and how BIV201 is being positioned to advance toward a pivotal study in refractory ascites.
Watch our full interview: https://t.co/sdeeBRCTTA
$BIVI $PACB $VYGR $PFE $MRK
Critical minerals are increasingly viewed as strategic infrastructure inputs rather than cyclical commodities.
Avalon Advanced Materials $AVL | $AVLNF is advancing domestic sources of rare earth elements and battery-grade lithium - materials required for power systems, data infrastructure, clean technologies, and advanced industrial applications across North America. @AvalonAdvanced’s approach emphasizes long-duration demand drivers and responsible development aligned with government and industry priorities.
Explore Avalon’s role in North America’s critical minerals supply chain: https://t.co/qNbZgK5pE3
$AVLNF $MP $ARA $ILU $PPTA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO